Olalekan Oluwole

February 18, 2026

Patient with melanoma receives tumor-infiltrating lymphocyte therapy

The highly personalized treatment is currently approved for patients with advanced stages of melanoma whose tumors have grown despite immunotherapies and/or targeted therapies.

By Tom Wilemon
(photo by Erin O. Smith)
December 4, 2025

Vanderbilt-Ingram researchers present cancer advancements at ASH 2025 

Established in 1958, ASH is the world’s largest professional organization for clinicians and scientists who study blood diseases. 

By Tom Wilemon